EUVIMEDEUVIMED entdecken
Crossref

Co-delivery of doxorubicin and glycyrrhetinic acid via acid/glutathione dual responsive nano-prodrug with sodium bicarbonate carry-on for advanced combinational cancer treatment

Chuan Hu, Jiaqi Ma, Ziye Su, Junyu Wang, Xueqian Zhang, Lin Pang, Yan Qu, Jinfeng Shi, Jinming Zhang

Journal of Colloid and Interface Science · 2025-06 · 687 · 248-260

DOI: 10.1016/j.jcis.2025.02.045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Colloid and Interface Science, 2025-06. Verfasst von Chuan Hu und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 6111…. Hauptthemen laut MEDLINE: Doxorubicin, Glycyrrhetinic Acid, Glutathione, Sodium Bicarbonate. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chengdu Medical College.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The combination of doxorubicin (Dox) and glycyrrhetinic acid (GA) has been widely explored for treating various cancers, while the heterogeneous distribution, uncontrolled release and acid tumor microenvironment often hinder their synergistic effects. Herein, we introduce an acid/glutathione (GSH)-dual responsive nano-prodrug (AS1411@Dox+GA/NPs) enabling precise co-delivery of Dox and GA for enhanced combination therapy. The GSH-activated Dox prodrug [Poly(lactic-co-glycolic acid)-disulfide-Dox, PLGA-ss-Dox], GA, and sulfur-terminated D-α-tocopherol polyethylene glycol succinate (TPGS-SH) are combined to form a nanoemulsion with sodium bicarbonate (NaHCO3) in the aqueous phase. The AS1411 aptamer is modified on the surface for tumor-specific targeting. Upon reaching the tumor via enhanced penetration and retention effects, AS1411 aptamer medicates specific endocytosis of AS1411@Dox+GA/NPs into tumor cells. Intracellularly, the acidic endosomal environment promotes carbon dioxide (CO2) production from NaHCO3, disrupting the nanoemulsion and causing a burst release of GA and PLGA-ss-Dox prodrug. Concurrently, high levels of GSH in the cytoplasm triggers the cleavage of the disulfide linker, thereby releasing Dox. Notably, the released NaHCO3 consumed hydrogen ion (H+), amplifying the sensitivity of tumor cells to Dox. As a consequence, AS1411@Dox+GA/NPs exhibits remarkable synergistic therapeutic efficacy in mouse models of both liver cancer and breast cancer. This work presents an appealing approach utilizing stimuli-sensitive nano-prodrug for advanced combinational cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinGlycyrrhetinic AcidGlutathioneSodium BicarbonateProdrugsNanoparticlesAntibiotics, AntineoplasticAnimalsHumansMiceFemaleMice, Inbred BALB CParticle SizeDrug LiberationDrug Screening Assays, AntitumorCell SurvivalDrug Delivery SystemsCell ProliferationSurface Properties

Stichwörter der Autor:innen

Combination therapyControlled drug releaseMicroenvironment regulationNano-prodrugStimuli-responsive

Substanzen

DoxorubicinGlycyrrhetinic AcidGlutathioneSodium BicarbonateProdrugsAntibiotics, Antineoplastic

Autor:innen und Institutionen

  • State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
  • College of Pharmacy, Chengdu Medical College, Chengdu 610500, China.
  • College of Pharmacy, Chengdu Medical College, Chengdu 610500, China. Electronic address: shijinfengss@126.com.
  • State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China. Electronic address: cdutcmzjm@126.com.

Förderung

  • National Natural Science Foundation of China
  • Chengdu Medical College

Zitieren

APA

Hu, C., Ma, J., Su, Z., Wang, J., Zhang, X., Pang, L., Qu, Y., Shi, J., & Zhang, J. (2025). Co-delivery of doxorubicin and glycyrrhetinic acid via acid/glutathione dual responsive nano-prodrug with sodium bicarbonate carry-on for advanced combinational cancer treatment. Journal of Colloid and Interface Science, 687, 248-260. https://doi.org/10.1016/j.jcis.2025.02.045

Vancouver

Hu C, Ma J, Su Z, Wang J, Zhang X, Pang L, et al. Co-delivery of doxorubicin and glycyrrhetinic acid via acid/glutathione dual responsive nano-prodrug with sodium bicarbonate carry-on for advanced combinational cancer treatment. Journal of Colloid and Interface Science. 2025;687:248-260. doi:10.1016/j.jcis.2025.02.045

BibTeX
@article{Hu2025,
  author = {Hu, Chuan and Ma, Jiaqi and Su, Ziye and Wang, Junyu and Zhang, Xueqian and Pang, Lin and Qu, Yan and Shi, Jinfeng and Zhang, Jinming},
  title = {Co-delivery of doxorubicin and glycyrrhetinic acid via acid/glutathione dual responsive nano-prodrug with sodium bicarbonate carry-on for advanced combinational cancer treatment},
  journal = {Journal of Colloid and Interface Science},
  year = {2025},
  volume = {687},
  pages = {248--260},
  doi = {10.1016/j.jcis.2025.02.045}
}
Kostenlos starten →